Cervical cancer survival rates based on cancer stages
Cervical cancer survival rates are based on the percentage of people with the same type and stage of cancer who are alive after their diagnosis for a certain amount of time. Usually, cervical cancer survival rates are given as five-year survival rates.
The very earliest stage, known as stage 0 (also called carcinoma in situ), which involves cancer cells found only in the innermost lining of the cervix, has a high survival rate — 93 percent.
- Stage 1 cervical cancer is also a very early stage of the disease and has a good prognosis. The size of the malignancy and whether it has started to spread into cervical tissue influence the survival rates, which range from 93 to 80 percent.
- Stage II cervical cancer survival rates range from 63 to 58 percent, reflecting the degree the cancer has spread just beyond the cervix and the size of the tumor.
- Stage III cervical cancer has spread to the lower third of the vagina. It may also have spread onto the pelvic wall and may cause kidney problems. Survival rates range from 35 to 32 percent, depending on how far the cancer has spread and the size of the malignancy.
- Stage IV cervical cancer has spread beyond the pelvis to the lining of the bladder /or rectum or to other parts of the body. Survival rate is around 15 to 16 percent, depending on where the malignancy has spread.
What cervical cancer survival rates don’t tell you
Even if you are diagnosed with a late stage of cervical cancer, there are often treatment options available. And the outlook for your own survival is influenced by the factors of your specific case, according to the American Cancer Society.
For example, your age, your overall physical condition, whether you have other serious conditions, and how well your cancer responds to treatment all play important roles in the outcome of your individual situation.
Talk to your doctor about how cervical cancer survival rates apply to you and what measures you can take to help achieve the best outcome possible for your cancer treatment — and your future.
January 08, 2018
Janet O’Dell, RN